X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC LTD with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs TEVA PHARMA (Israel) - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC LTD   TEVA PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
TEVA PHARMA
Dec-13
ALEMBIC LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs532,716-   
Low Rs292,359-   
Sales per share (Unadj.) Rs4.71,558.5-  
Earnings per share (Unadj.) Rs8.897.4-  
Cash flow per share (Unadj.) Rs9.0223.3-  
Dividends per share (Unadj.) Rs0.1585.23-  
Dividend yield (eoy) %0.43.4 10.9%  
Book value per share (Unadj.) Rs27.71,731.2-  
Shares outstanding (eoy) m267.03848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.71.6 534.2%   
Avg P/E ratio x4.726.1 18.0%  
P/CF ratio (eoy) x4.611.4 40.1%  
Price / Book Value ratio x1.51.5 101.0%  
Dividend payout %1.787.5 2.0%   
Avg Mkt Cap Rs m10,9622,151,664 0.5%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2380-   
Avg. sales/employee Rs ThNM29,405.5-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,836.9-  
INCOME DATA
Net Sales Rs m1,2601,321,629 0.1%  
Other income Rs m2640-   
Total revenues Rs m1,5241,321,629 0.1%   
Gross profit Rs m83361,929 0.0%  
Depreciation Rs m61106,829 0.1%   
Interest Rs m025,959 0.0%   
Profit before tax Rs m285229,141 0.1%   
Minority Interest Rs m01,041 0.0%   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-32-150,419 0.0%   
Tax Rs m6-2,798 -0.2%   
Profit after tax Rs m2,34382,561 2.8%  
Gross profit margin %6.627.4 24.0%  
Effective tax rate %2.1-1.2 -175.4%   
Net profit margin %185.96.2 2,975.7%  
BALANCE SHEET DATA
Current assets Rs m1,689892,623 0.2%   
Current liabilities Rs m486778,443 0.1%   
Net working cap to sales %95.48.6 1,104.5%  
Current ratio x3.51.1 302.9%  
Inventory Days Days21791 238.9%  
Debtors Days Days8196 84.5%  
Net fixed assets Rs m1,624431,673 0.4%   
Share capital Rs m5343,253 16.4%   
"Free" reserves Rs m5,9600-   
Net worth Rs m7,4041,468,079 0.5%   
Long term debt Rs m104675,778 0.0%   
Total assets Rs m8,0103,020,345 0.3%  
Interest coverage x950.79.8 9,674.0%   
Debt to equity ratio x00.5 3.1%  
Sales to assets ratio x0.20.4 36.0%   
Return on assets %29.33.6 814.1%  
Return on equity %31.65.6 562.7%  
Return on capital %31.34.9 634.5%  
Exports to sales %2.90-   
Imports to sales %28.90-   
Net fx Rs m-3280-   
CASH FLOW
From Operations Rs m346210,599 0.2%  
From Investments Rs m-48-74,624 0.1%  
From Financial Activity Rs m-301-252,628 0.1%  
Net Cashflow Rs m-3-116,653 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 65.06 Rs / USD

Compare ALEMBIC LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ALEMBIC LTD With: CADILA HEALTHCARE  WYETH LTD  STERLING BIOTECH  ALKEM LABORATORIES  MERCK LTD  



Today's Market

Sensex Trades in Red; PSU & Energy Stocks Decline(01:30 pm)

Indian share markets continued to trade in red during the noon session weak Asian markets. PSU stocks and energy stocks are witnessing majority of the selling activity.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 22, 2018 02:55 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS